A clinical trial deals with the application of specific clinical or scientific methods or medicine to the human body. Clinical trials are used to identify the effect of particular treatment or medication on patients suffering from a particular disease. The process of a clinical trial starts with identification of the medication or medical device to be tested. Participants for the trial are selected and the results are studied in order to define the effectiveness of the drug or device.

Clinical trials are very crucial as they involve huge capital investment and may affect the subjects involved. Thus proper management of clinical trials has become a priority for the hospitals. Clinical Trial Management System is a software system employed to manage the large amounts of data involved in a clinical trial. It maintains the planning, preparation, performance, and reporting of clinical trials, including participant information, trial and filing deadlines and other important milestones. The global market was valued at $576.22 million in 2010 and estimated to grow at a CAGR of 14.53% during the study period (2011-2016).

Improved clinical trial efficiency with optimized process; centralized database; improved site performance by enhanced investigator relationships; higher subject accrual rate & reduced workload for research coordinators; efficiency in budgeting and financial management; improved cost efficiencies; improved clinical research associate productivity; and automated data processing and report generating are some of the key advantages that are driving the market.

Clinical Trial Management System is used by the clinical trial organizations such as Pharmaceutical/Biopharmaceutical Companies, Clinical Research Organizations (CROs), and Healthcare providers (Hospitals, Academic Medical Centers (AMCs) which handle clinical trial. The pharmaceutical CTMS market contributed the largest share; i.e. 49% in 2010. Clinical Research Organizations (CRO) and Healthcare providers contributes 46% and 5% respectively in 2010.

Based on the mode of delivery, the global market is divided into three types; i.e. web-based, on-Premise and cloud-based. Among all these segments, the web-based market is forecasted to witness the highest CAGR of 15.95% from 2011 to 2016 and is estimated to capture 75% share by 2016 from 70% share in 2010. On-premise and cloud-based (SAAS) CTMS contributes 28% and 2% respectively in 2010.

North America dominated the global market with around 62% share in 2010. The U.S. captures the largest market share of North America, and shows a remarkable growth opportunity. The second largest market, Europe, while growth in the Asia-Pacific region is also expected to take greater curves in the near future.

Scope of the Report

This Clinical Trial Management Systems market research report will enable strategic understanding of the following key segments of the market:

Global market, by end-users:

• Pharmaceutical/biopharmaceutical
• Clinical Research Organizations (CRO’s)
• Healthcare Providers (Academic institutions/universities, hospitals, and research institutions)

Global market, by types:

• Enterprise 
• Site 

Global market, by components:

• Hardware
• Software
• Services

Global market, by delivery mode:

• On-premises (Licensed Enterprise)
• Web-based (Web-hosted)
• Cloud-based
• The geographies covered under the report are –

North America

• U.S.
• Canada

Europe

Asia

ROW (Rest of the World)

Each section of the report offers market data for the various market segments and geographies. It also provides market trends with respect to drivers, restraints, and opportunities. The report’s “strategy” section sketches the competitive landscape with about four company profiles.

TABLE OF CONTENTS   
   
1 INTRODUCTION  
  1.1 KEY TAKE-AWAYS  
  1.2 REPORT DESCRIPTION  
  1.3 MARKETS COVERED  
  1.4 STAKEHOLDERS  
  1.5 RESEARCH METHODOLOGY  
      1.5.1 MARKET SIZE  
      1.5.2 ASSUMPTIONS MADE FOR THE REPORT  
   
2 SUMMARY  
   
3 MARKET OVERVIEW  
  3.1 INTRODUCTION  
      3.1.1 CLINICAL TRIAL DEFINITION  
      3.1.2 CLINICAL TRIAL PROCESS  
      3.1.3 CLINICAL TRIAL MANAGEMENT SYSTEM DEFINITION  
  3.2 ECLINICAL PROCESS & ECLINICAL PLATFORM  
  3.3 MARKET DYNAMICS  
      3.3.1 DRIVERS  
            3.3.1.1 Introduction  
            3.3.1.2 Ensures patient safety  
            3.3.1.3 Mitigates costs and offers competitive advantage  
            3.3.1.4 Secured anytime, anywhere access of web-based and cloud-based CTMS offerings  
            3.3.1.5 CTMS Integration with other Hospital Information Systems (HIS)  
      3.3.2 RESTRAINTS  
            3.3.2.1 Lack of awareness of CTMS in the research community  
            3.3.2.2 High cost of the system restricts the user count  
            3.3.2.3 Flexibility issues are more with on-premise CTMS model  
      3.3.3 OPPORTUNITIES  
            3.3.3.1 Shift of clinical trials and resources from AMCs to CROs in the past decade  
            3.3.3.2 Increasing clinical trial Outsourcing trend form Asian countries  
      3.3.4 MARKET SHARE ANALYSIS, BY COMPETITOR  
   
4 BENEFITS OF CTMS (KEY NEEDS AND BENEFITS INFLUENCING PURCHASING DECISIONS)  
  4.1 IMPROVED CLINICAL TRIAL EFFICIENCY WITH OPTIMIZED PROCESS & CENTRALIZED DATABASE  
  4.2 IMPROVES SITE PERFORMANCE BY ENHANCED INVESTIGATOR RELATIONSHIPS  
  4.3 HIGHER SUBJECT ACCRUAL RATE & REDUCED WORKLOAD FOR RESEARCH COORDINATORS  
  4.4 EFFECTIVELY MANAGE THE BUDGETING & BILLING ACTIVITES ASSOCIATED WITH CLINICAL TRIALS  
  4.5 IMPROVED COST EFFICIENCIES THROUGH REDUCED DATA ENTRY AT MULTIPLE SITE & MANUAL LABOR COSTS  
  4.6 IMPROVED CLINICAL RESEARCH ASSOCIATE PRODUCTIVITY  
  4.7 AUTOMATED DATA PROCESSING & REPORT GENERATING  
   
5 CHALLENGES/LIMITATIONS/UNMET NEEDS  
 5.1 EVOLUTION OF CTMS SYSTEM IN A TIMELY MANNER TO IMPROVE THE BUSINESS PROCESS  
  5.2 INTEROPERABILITY & INTEGRATION ISSUES  
  5.3 EXTENSIBILITY  
  5.4 SKEPTICISM IN USAGE & APPLICATIONS  
 5.5 COST & DURATION OF DEPLOYMENT  
   
6 COMPONENTS OF A CTMS (DRIVERS INFLUENCING THE BUYING PATTERN)  
  6.1 INTRODUCTION  
  6.2 PROTOCOL DESIGN & STUDY START UP  
  6.3 PATIENT & INVESTIGATOR RECRUITMENT  
  6.4 FINANCIAL MANAGEMENT & BILLING SOLUTIONS  
  6.5 CLINICAL DATA TRACKING & DATA ANALYSIS MODULE (PATIENT DATA MANAGEMENT & SITE MANAGEMENT)  
  6.6 DOCUMENT MANAGEMENT SYSTEM (REGULATORY DOCUMENT MANAGEMENT & PROGRESS REPORTS)  
  6.7 CLINICAL SUPPLIES MANAGEMENT  
  6.8 ADVERSE EVENTS (AE) & SERIOUS ADVERSE EVENTS (SAE) MANAGEMENT  
  6.9 CENTRAL DOCUMENT REPOSITORY  
   
7 MARKET BY END-USER (TARGET MARKET FOR CTMS)  
  7.1 INTRODUCTION  
  7.2 CLINICAL RESEARCH ORGANIZATIONS (CROS) CTMS MARKET  
  7.3 PHARMACEUTICAL CTMS MARKET  
  7.4 HEALTHCARE PROVIDERS CTMS MARKET  
   
8 MARKET BY DELIVERY MODE  
  8.1 INTRODUCTION  
  8.2 WEB-BASED (HOSTED) CTMS  
  8.3 LICENSED ENTERPRISE (ON PREMISE) CTMS  
  8.4 CLOUD-BASED (SAAS) CTMS  
   
9 MARKET BY COMPONENTS  
  9.1 INTRODUCTION  
  9.2 SOFTWARE  
  9.3 HARDWARE  
  9.4 SERVICES  
   
10 MARKET BY CTMS TYPE  
  10.1 INTRODUCTION  
  10.2 ENTERPRISE CTMS  
  10.3 SITE CTMS  
   
11 CTMS PENETRATION  
   
12 GEOGRAPHICAL ANALYSIS  
  12.1 INTRODUCTION  
  12.2 NORTH AMERICA  
      12.2.1 U.S.  
      12.2.2 CANADA  
  12.3 EUROPE  
  12.4 ASIA  
  12.5 REST OF THE WORLD (ROW)  
   
13 CLINICAL TRIALS  
  13.1 INTRODUCTION  
  13.2 MARKET DYNAMICS FOR CLINICAL TRIALS  
      13.2.1 DRIVERS  
            13.2.1.1 Globalizing drug development activities  
            13.2.1.2 Rise in R&D investments expected to boost the clinical trials market  
            13.2.1.3 High disease prevalence in emerging countries  
      13.2.2 RESTRAINT  
            13.2.2.1 Longer approval time for clinical trials – A cause of concern for major pharmaceutical/ biopharmaceutical players  
      13.2.3 BURNING ISSUES  
            13.2.3.1 Out skirting boundaries of medical ethics  
      13.2.4 WINNING IMPERATIVE  
            13.2.4.1 Leveraging online resources to increase patient recruitment rates in clinical trials  
  13.3 CLINICAL TRIAL OUTSOURCING & ROLE OF ACADEMIC RESEARCH ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS  
      13.3.1 TRADITIONAL ROLE OF ACADEMIC RESEARCH CENTERS IN CONDUCTING CLINICAL TRIALS  
      13.3.2 TRADITIONAL ROLE OF CROS IN CONDUCTING CLINICAL TRIALS  
      13.3.3 EVOLVING ROLE OF ACADEMIC RESEARCH CENTERS IN CONDUCTING CLINICAL TRIALS  
            13.3.3.1 Following are considered as the Key reasons for loss of Market share of AMCs in Clinical trials  
                    13.3.3.1.1 Proliferation of global trials  
                    13.3.3.1.2 Clinical trial duration  
                    13.3.3.1.3 Lack of Self financing capability  
                    13.3.3.1.4 Development of In-house CROs of Pharmaceutical companies  
                    13.3.3.1.5 Increasing clinical trial costs  
      13.3.4 EVOLVING ROLE OF CROS IN CONDUCTING CLINICAL TRIALS  
            13.3.4.1 Full service model  
            13.3.4.2 Hourly billing model  
            13.3.4.3 Full time equivalent model (FTE)  
            13.3.4.4 Fixed price model  
  13.4 CLINICAL TRIALS BY PLAYERS  
      13.4.1 BY INDUSTRY (CRO, NPO, PHARMACEUTICAL INDUSTRY)  
      13.4.2 BY INDUSTRY + HEALTHCARE PROVIDERS  
      13.4.3 BY OTHERS (U.S. FEDERAL ADMINISTRATION & NIH, OTHERS)  
   
14 COMPETITIVE LANDSCAPE  
  14.1 INTRODUCTION  
  14.2 COMPETITIVE DEVELOPMENTS  
      14.2.1 MERGERS & ACQUISITIONS  
      14.2.2 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/ CONTRACTS  
      14.2.3 NEW PRODUCTS LAUNCH  
      14.2.4 EXPANSIONS/NEW FACILITY/INVESTMENTS  
      14.2.5 OTHERS/FDA APPROVALS/GOVERNMENT GRANTS  
   
15 COMPANY PROFILES  
  15.1 ARIS GLOBAL LLC  
      15.1.1 OVERVIEW  
      15.1.2 FINANCIALS  
      15.1.3 PRODUCTS & SERVICES  
      15.1.4 STRATEGY  
      15.1.5 DEVELOPMENTS  
  15.2 BIOCLINICA INC.  
      15.2.1 OVERVIEW  
      15.2.2 FINANCIALS  
      15.2.3 PRODUCTS & SERVICES  
      15.2.4 STRATEGY  
      15.2.5 DEVELOPMENTS  
  15.3 BIO-OPTRONICS INC.  
      15.3.1 OVERVIEW  
      15.3.2 FINANCIALS  
      15.3.3 PRODUCTS & SERVICES  
      15.3.4 STRATEGY  
      15.3.5 DEVELOPMENTS  
  15.4 BUSINESS SYSTEMS INTEGRATION AG  
      15.4.1 OVERVIEW  
      15.4.2 FINANCIALS  
      15.4.3 PRODUCTS & SERVICES  
      15.4.4 STRATEGY  
      15.4.5 DEVELOPMENTS  
  15.5 DIGIPORT HOLDINGS PRIVATE LTD  
      15.5.1 OVERVIEW  
      15.5.2 FINANCIALS  
      15.5.3 PRODUCTS & SERVICES  
      15.5.4 STRATEGY  
      15.5.5 DEVELOPMENTS  
  15.6 DSG INC.  
      15.6.1 OVERVIEW  
      15.6.2 FINANCIALS  
      15.6.3 PRODUCTS & SERVICES  
      15.6.4 STRATEGY  
      15.6.5 DEVELOPMENTS  
  15.7 ERESEARCH TECHNOLOGY INC. (ERT)  
      15.7.1 OVERVIEW  
      15.7.2 FINANCIALS  
      15.7.3 PRODUCTS & SERVICES  
      15.7.4 STRATEGY  
      15.7.5 DEVELOPMENTS  
  15.8 FORTE RESEARCH SYSTEMS  
      15.8.1 OVERVIEW  
      15.8.2 FINANCIALS  
      15.8.3 PRODUCTS & SERVICES  
      15.8.4 STRATEGY  
      15.8.5 DEVELOPMENTS  
  15.9 GOBALTO  
      15.9.1 OVERVIEW  
      15.9.2 FINANCIALS  
      15.9.3 PRODUCTS & SERVICES  
      15.9.4 STRATEGY  
      15.9.5 DEVELOPMENTS  
  15.10 INNOVOCOMMERCE LLC  
      15.10.1 OVERVIEW  
      15.10.2 FINANCIALS  
      15.10.3 PRODUCTS & SERVICES  
      15.10.4 STRATEGY  
      15.10.5 DEVELOPMENTS  
  15.11 INTEGRATED CLINICAL SOLUTIONS INC.  
      15.11.1 OVERVIEW  
      15.11.2 FINANCIALS  
      15.11.3 PRODUCTS & SERVICES  
      15.11.4 STRATEGY  
      15.11.5 DEVELOPMENT  
  15.12 MEDIDATA SOLUTIONS  
      15.12.1 OVERVIEW  
      15.12.2 FINANCIALS  
      15.12.3 PRODUCTS & SERVICES  
      15.12.4 STRATEGY  
      15.12.5 DEVELOPMENTS  
  15.13 MEDNET SOLUTIONS  
      15.13.1 OVERVIEW  
      15.13.2 FINANCIALS  
      15.13.3 PRODUCTS & SERVICES  
      15.13.4 STRATEGY  
      15.13.5 DEVELOPMENTS  
  15.14 MERGE HEALTHCARE INCORPORATED  
      15.14.1 OVERVIEW  
      15.14.2 FINANCIALS  
      15.14.3 PRODUCTS & SERVICES  
      15.14.4 STRATEGY  
      15.14.5 DEVELOPMENTS  
  15.15 NEXTRIALS INC.  
      15.15.1 OVERVIEW  
      15.15.2 FINANCIALS  
      15.15.3 PRODUCTS & SERVICES  
      15.15.4 STRATEGY  
      15.15.5 DEVELOPMENTS  
  15.16 OMNICOMM SYSTEMS INC.  
      15.16.1 OVERVIEW  
      15.16.2 FINANCIALS  
      15.16.3 PRODUCTS & SERVICES  
      15.16.4 STRATEGY  
      15.16.5 DEVELOPMENTS  
  15.17 ORACLE CORPORATION  
      15.17.1 OVERVIEW  
      15.17.2 FINANCIALS  
      15.17.3 PRODUCTS & SERVICES  
      15.17.4 STRATEGY  
      15.17.5 DEVELOPMENTS  
  15.18 ORIAM  
      15.18.1 OVERVIEW  
      15.18.2 FINANCIALS  
      15.18.3 PRODUCTS & SERVICES  
      15.18.4 STRATEGY  
      15.18.5 DEVELOPMENTS  
  15.19 PAREXEL INTERNATIONAL CORPORATION  
      15.19.1 OVERVIEW  
      15.19.2 FINANCIALS  
      15.19.3 PRODUCTS & SERVICES  
      15.19.4 STRATEGY  
      15.19.5 DEVELOPMENTS  
  15.20 SPARTA SYSTEMS INC.  
      15.20.1 OVERVIEW  
      15.20.2 FINANCIALS  
      15.20.3 PRODUCTS & SERVICES  
      15.20.4 STRATEGY  
      15.20.5 DEVELOPMENTS  
      15.21 STUDYMANAGER INC.  
      15.21.1 OVERVIEW  
      15.21.2 FINANCIALS  
      15.21.3 PRODUCTS & SERVICES  
      15.21.4 STRATEGY  
  15.21.5 DEVELOPMENTS  
      15.22 TRIAL BY FIRE SOLUTIONS  
      15.22.1 OVERVIEW  
      15.22.2 FINANCIALS  
      15.22.3 PRODUCTS & SERVICES  
      15.22.4 STRATEGY  
  15.22.5 DEVELOPMENTS  
      15.23 OTHERS  
      15.23.1 ECLINFORCE INC.  
            15.23.1.1 Overview  
            15.23.1.2 Financials  
            15.23.1.3 Products & services  
  15.23.1.4 Strategy  
      15.23.2 VOLODYNE TECHNOLOGIES  
            15.23.2.1 Overview  
            15.23.2.2 Financials  
            15.23.2.3 Products & services  
            15.23.2.4 Strategy  
      15.23.3 DATABEAN LLC  
            15.23.3.1 Overview  
            15.23.3.2 Financials  
            15.23.3.3 Products & services  
            15.23.3.4 Strategy  
      15.23.4 CLINTRIAL WORKS  
            15.23.4.1 Overview  
            15.23.4.2 Financials  
            15.23.4.3 Products & services  
            15.23.4.4 Strategy   
   
LIST OF TABLES   
   
TABLE 1 CTMS MARKET SIZE, BY GEOGRAPHY, 2008 – 2016 (MILLION)  
TABLE 2 GLOBAL CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)  
TABLE 3 CRO CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 4 NORTH AMERICA: CRO CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 5 PHARMACEUTICAL CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 6 NORTH AMERICA: PHARMACEUTICAL CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 7 PROVIDER CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 8 NORTH AMERICA: PROVIDER CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 9 CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)  
TABLE 10 WEB-BASED CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 11 NORTH AMERICA: WEB-BASED CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 12 ON-PREMISE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 13 NORTH AMERICA: ON-PREMISE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 14 CLOUD-BASED CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 15 NORTH AMERICA: CLOUD-BASED CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 16 CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)  
TABLE 17 SOFTWARE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 18 NORTH AMERICA: SOFTWARE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 19 HARDWARE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 20 NORTH AMERICA: HARDWARE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 21 SERVICES CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 22 NORTH AMERICA: SERVICES CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 23 CTMS MARKET REVENUE, BY TYPES, 2008 – 2016 ($MILLION)  
TABLE 24 ENTERPRISE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 25 NORTH AMERICA: ENTERPRISE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($ MILLION)  
TABLE 26 SITE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
TABLE 27 NORTH AMERICA: SITE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 28 CTMS PENETRATION, BY GEOGRAPHY, 2010  
TABLE 29 NORTH AMERICA: CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)  
TABLE 30 NORTH AMERICA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)  
TABLE 31 NORTH AMERICA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)  
TABLE 32 NORTH AMERICA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)  
TABLE 33 NORTH AMERICA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)  
TABLE 34 U.S: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)  
TABLE 35 U.S: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)  
TABLE 36 U.S.: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)  
TABLE 37 U.S: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)  
TABLE 38 CANADA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)  
TABLE 39 CANADA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)  
TABLE 40 CANADA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)  
TABLE 41 CANADA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)  
TABLE 42 EUROPE: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)  
TABLE 43 EUROPE: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)  
TABLE 44 EUROPE: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)  
TABLE 45 EUROPE: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)  
TABLE 46 ASIA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)  
TABLE 47 ASIA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)  
TABLE 48 ASIA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)  
TABLE 49 ASIA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)  
TABLE 50 ROW: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)  
TABLE 51 ROW: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)  
TABLE 52 ROW: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)  
TABLE 53 ROW: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)  
TABLE 54 MARKET SHARE OF HEALTHCARE PROVIDERS IN GLOBAL CLINICAL TRIALS, 1998 – 2007  
TABLE 55 DRIFT OF NORTH AMERICAN SHARE IN GLOBAL CLINICAL TRIAL, 1990 – 2007  
TABLE 56 BIOCLINICA INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)  
TABLE 57 BIOCLINICA INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)  
TABLE 58 ERESEARCH TECHNOLOGY INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)  
TABLE 59 ERESEARCH TECHNOLOGY INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)  
TABLE 60 ERESEARCH TECHNOLOGY INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)  
TABLE 61 MEDIDATA SOLUTIONS: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)  
TABLE 62 MEDIDATA SOLUTIONS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)  
TABLE 63 MEDIDATA SOLUTIONS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)  
TABLE 64 MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)  
TABLE 65 MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)  
TABLE 66 MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)  
TABLE 67 OMNICOMM SYSTEMS INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)  
TABLE 68 ORACLE CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)  
TABLE 69 ORACLE CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)  
TABLE 70 ORACLE CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)  
TABLE 71 PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)  
TABLE 72 PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)  
TABLE 73 PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)  
    
   
LIST OF FIGURES   
   
FIGURE 1 PROCESS OF CLINICAL TRIALS  
FIGURE 2 DRIVERS & RESTRAINTS FOR CTMS MARKET  
FIGURE 3 MARKET SHARE ANALYSIS, BY COMPETITORS, (BASED ON SOFTWARE LICENSE REVENUE SHARE), 2010  
FIGURE 4 MODULES OF CTMS  
FIGURE 5 CTMS MARKET, BY END-USERS, 2010  
FIGURE 6 CTMS MARKET, BY DELIVERY MODE, 2010 VS. 2016  
FIGURE 7 CTMS MARKET SHARE, BY COMPONENTS, 2010  
FIGURE 8 CTMS PENETRATION, BY GEOGRAPHY, 2010 (%)  
FIGURE 9 CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)  
FIGURE 10 MARKET SHARE OF HEALTHCARE PROVIDERS IN GLOBAL CLINICAL TRIALS, 1998 VS 2007  
FIGURE 11 DRIFT OF NORTH AMERICAN SHARE IN GLOBAL CLINICAL TRIAL, 1990 – 2007  
FIGURE 12 GRANT FUNDED VS. SELF FINANCING TRIALS  
FIGURE 13 INDUSTRY VS AMC WITH/WITHOUT GRANT VS NIH/U.S. FED ALONE  
FIGURE 14 INDUSTRY VS. INDUSTRY PLUS AMC  
FIGURE 15 INDUSTRY VS. AMC VS. U.S. FED PLUS NIH  
FIGURE 16 INDUSTRY VS. AMC VS. US FED VS. NIH  
FIGURE 17 KEY GROWTH STRATEGIES, 2008 – 2011  

A clinical trial deals with the application of specific clinical or scientific methods or medicine to human body. Clinical trials are used to identify the effect of particular treatment or medication on patients suffering from a particular disease. The process of a clinical trial starts with identification of the medication or the medical device to be tested. Participants for the trial are selected and the results are studied in order to define the effectiveness of the drug or device.

Clinical trials are very crucial as they involve huge capital investment and may affect the subjects involved. Thus proper management of clinical trials has become a priority for the hospitals.

Clinical Trial Management Systems market was globally 34% penetrated in 2010. Global market was valued at $576.22 million in 2010, and is estimated to reach $1300.4 million by 2016, growing at a CAGR of 14.53%.

This syatem is used by the clinical trial organizations such as Pharmaceutical/Biopharmaceutical Companies, Clinical Research Organizations (CROs), and Healthcare providers (Hospitals, Academic Medical Centers (AMCs) which handle clinical trial process as a part of drug/therapeutic research and development and also other forms of clinical trials such as post-marketing surveillance, behavioral studies or trials and more.

CTMS Market, By End-Users, 2010

Source: MarketsandMarkets Analysis

The pharmaceutical CTMS market contributed the largest share; i.e. 49% in 2010. Clinical Research Organizations (CRO) CTMS market is the second largest contributor with 46% share in 2010; whereas CRO’s market is estimated to grow at a higher CAGR to capture 51% market share by 2016.